Clinical trials: Migraine, completed
Depression, Headaches Chronic
CBT Depression Intervention for Co-Occurring Chronic Headache
Having co-occurring depression and chronic headaches is challenging and can greatly impact one's professional, personal, family, and social life.
- Conditions
- Depression, Headaches Chronic, Migraine Disorders
- Trial name
- NCT02870725
- Testing
- CBT Individual Psychotherapy
- Where
- 2 sites in United States
- Volunteers
- 22 people
- Sponsor
- University of Georgia
Migraine in Adolescents
Bringing Relief to Adolescents Naturally Using Melatonin for Migraine
Migraine in adolescents is common and effective and safe preventive treatments are needed. This is a pilot randomized controlled trial of melatonin versus placebo for migraine prevention in adolescents 12-17 years old.
- Trial name
- BRAiN-M (NCT02344316)
- Testing
- Melatonin
- Where
- 2 sites in United States
- Volunteers
- 31 people
- Sponsor
- Amy Gelfand
Acute Migraine
A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
This trial is to evaluate the long-term safety and tolerability of Rimegepant 75mg ODT in Chinese subjects with migraine
- Trial name
- NCT05371652
- Testing
- Rimegepant 75mg Orally Disintegrating Tablets (ODT)
- Where
- 26 sites in China
- Volunteers
- 241 people
- Sponsor
- Pfizer
Migraine
Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
To evaluate the reduction of emotional burden (measured by Relative Stress Scale-RSS) of caregivers of migraine patients with Depressive Symptoms after 6 months after the first injection of fremanezumab.
- Trial name
- NCT07029126
- Testing
- Fremanezumab
- Where
- 10 sites in Italy
- Volunteers
- 308 people, healthy volunteers welcome
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
Pain, Migraine Disorders
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
The purpose of this study is to determine the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-04427429 in healthy women.
- Trial name
- NCT01511497
- Testing
- PF-04427429, Normal saline
- Where
- 3 sites in United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Pfizer
Migraine With Aura
Partial Rebreathing in the Treatment of Migraine With Aura
A study to test the efficacy of a partial rebreathing device in treating and/or preventing migraine pain
- Trial name
- CapnoMigra (NCT03472417)
- Testing
- Active partial rebreathing device, Dummy partial rebreathing device
- Where
- Denmark
- Volunteers
- 18 people
- Sponsor
- University of Aarhus
Acute Migraine
Transcranial Direct Current Stimulation for Migraine Attack
This study is conducted to investigate the therapeutic efficacy and safety of transcranial direct current stimulation (tDCS) over the primary motor cortex of patients with acute migraine attack.
- Trial name
- NCT01358279
- Testing
- transcranial direct current stimulation
- Where
- South Korea
- Volunteers
- 32 people
- Sponsor
- Seoul National University Hospital
Migraine Without Aura, Migraine With Aura
Impact of a Nurse for Migraine Management: the IMPACT Project
Headache disorders are prevalent, disabling, under recognized, under diagnosed and under treated. Migraine has a prevalence of 10% in men and 25% in women in Canada.
- Conditions
- Migraine Without Aura, Migraine With Aura, Chronic Migraine
- Trial name
- IMPACT (NCT01804517)
- Where
- Canada
- Volunteers
- 200 people
- Sponsor
- Notre-Dame Hospital, Montreal, Quebec, Canada
Familial Hemiplegic Migraine
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
The aim of the present study is to explore functional consequences of migraine gene mutations on their responses to Calcitonin Gene Related Peptide (CGRP)infusion.
- Trial name
- NCT00358839
- Testing
- CGRP
- Where
- Denmark
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Danish Headache Center
Migraine Without Aura
Functional MRI (fMRI) in CGRP Induced Migraine
In patients known with migraine without aura a migraine headache or migraine like headache will be induced by infusion of calcitonin gene related peptide (CGRP).
- Trial name
- NCT00363532
- Testing
- infusion of calcitonin gene related peptide (CGRP)
- Where
- Denmark
- Volunteers
- 12 people
- Sponsor
- Danish Headache Center
Vestibular Migraine
Effects of Lifestyle Modification on Vestibular Migraine
Vestibular migraine was recently addressed by the International Headache Society (IHS) as separate from other types of migraine. Vestibular migraine is one of the most common causes of vertigo attacks, affecting 1-5% of people.
- Trial name
- LMVM (NCT03979677)
- Testing
- Lifestyle Modifications
- Where
- United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Vanderbilt University Medical Center
Chronic Migraine
Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial
Cathodal tDCS decreases the excitability of the cerebral cortex and its daily application during intercritical phase, may have a therapeutic effect in chronic migraine.
- Trial name
- CATCHROMIG (NCT02122237)
- Testing
- Cefaly tDCS
- Where
- Belgium
- Volunteers
- 14 people
- Sponsor
- University of Liege
Migraine
A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
The purpose of this study is to evaluate the safety and the efficacy of Tianshu capsule treating Migraine Headache.
- Trial name
- NCT02035111
- Testing
- Tianshu capsule, Sugar pill
- Where
- 20 sites in China
- Volunteers
- 947 people
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
Refractory Migraine
Pulsed Electromagnetic Field Therapy in the Refractory Migraine
Pulsed electromagnetic field (PEMF) as prophylactic treatment may prevent the attacks of migraine or decrease them even in the patients with refractory migraine.
- Trial name
- NCT01670214
- Testing
- pulsed electromagnetic field
- Where
- Iran
- Volunteers
- 30 people
- Sponsor
- Niyayesh Clinic
Migraine, Migraine Disorders
Integrative Migraine Pain Alleviation Through Chiropractic Therapy
This pilot study evaluates the addition of chiropractic treatment to conventional neurological care in the treatment of migraine headaches in adult women.
- Conditions
- Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura
- Trial name
- IMPACT (NCT03177616)
- Testing
- Chiropractic Treatment
- Where
- United States
- Volunteers
- 61 people
- Sponsor
- Harvard University Faculty of Medicine
Migraine, Common Migraine
A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
The purpose of this study is to evaluate the safety and efficacy of three doses of topiramate (50 milligrams[mg], 100mg, and 200mg per day) compared with placebo in the prevention of migraine.
- Conditions
- Migraine, Common Migraine, Classic Migraine, Headache
- Trial name
- NCT00231595
- Testing
- topiramate
- Volunteers
- 768 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Acute Migraine
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
A study to provide evidence supporting the benefit of Rizatriptan in patients who have an inadequate response to sumatriptan.
- Trial name
- NCT00894556
- Testing
- rizatriptan, Comparator: Sumatriptan
- Volunteers
- 109 people
- Sponsor
- Organon and Co
Vascular Headaches, Migraine
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
The primary purpose of this study is to evaluate the effectiveness and safety of topiramate (an epilepsy medication) compared with placebo in the prevention of migraine.
- Trial name
- NCT00253175
- Testing
- topiramate
- Volunteers
- 211 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Migraine
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
The primary objective of the study is to evaluate the efficacy of fremanezumab as compared to placebo for the preventive treatment of episodic migraine (EM).
- Trial name
- NCT04458857
- Testing
- Fremanezumab
- Where
- 89 sites in United States, Canada and 7 more
- Volunteers
- 235 people
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
Migraine, Head Pain
CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study
Observational, prospective, descriptive, open study on response predictors and tolerability of Candesartan in patients >18 years with episodic or chronic migraine with prior failure of three or more preventive drugs.
- Trial name
- CandeSpartan (NCT04138316)
- Testing
- Candesartan
- Where
- Spain
- Volunteers
- 85 people
- Sponsor
- Hospital Clínico Universitario de Valladolid
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.